|
Name |
1-O-Deacetyl-2alpha-hydroxykhayanolide E
|
Molecular Formula | C27H32O11 | |
IUPAC Name* |
methyl (2S)-2-[(1S,2S,3S,4R,7S,8S,12R,14R,16R,17R,18S)-8-(furan-3-yl)-1,3,14-trihydroxy-7,16,18-trimethyl-10,15-dioxo-9,13-dioxahexacyclo[14.2.1.02,14.03,12.04,18.07,12]nonadecan-17-yl]-2-hydroxyacetate
|
|
SMILES |
C[C@@]12CC[C@@H]3[C@@]4([C@H]([C@]5(C[C@@]4([C@H]6[C@@]3([C@]1(CC(=O)O[C@H]2C7=COC=C7)O[C@]6(C5=O)O)O)O)C)[C@@H](C(=O)OC)O)C
|
|
InChI |
InChI=1S/C27H32O11/c1-21-11-24(32)19-26(33)13(23(24,3)16(21)15(29)18(30)35-4)5-7-22(2)17(12-6-8-36-10-12)37-14(28)9-25(22,26)38-27(19,34)20(21)31/h6,8,10,13,15-17,19,29,32-34H,5,7,9,11H2,1-4H3/t13-,15+,16+,17+,19+,21-,22+,23-,24+,25-,26+,27-/m1/s1
|
|
InChIKey |
ZDUBHZUNBSRUQC-UVQHVSCZSA-N
|
|
Synonyms |
1-O-Deacetyl-2alpha-hydroxykhayanolide E; 1189801-51-1; methyl (2S)-2-[(1S,2S,3S,4R,7S,8S,12R,14R,16R,17R,18S)-8-(furan-3-yl)-1,3,14-trihydroxy-7,16,18-trimethyl-10,15-dioxo-9,13-dioxahexacyclo[14.2.1.02,14.03,12.04,18.07,12]nonadecan-17-yl]-2-hydroxyacetate; ZINC100060215
|
|
CAS | NA | |
PubChem CID | 91895445 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 532.5 | ALogp: | -0.7 |
HBD: | 4 | HBA: | 11 |
Rotatable Bonds: | 4 | Lipinski's rule of five: | Rejected |
Polar Surface Area: | 173.0 | Aromatic Rings: | 7 |
Heavy Atoms: | 38 | QED Weighted: | 0.405 |
Caco-2 Permeability: | -5.507 | MDCK Permeability: | 0.00004620 |
Pgp-inhibitor: | 0.026 | Pgp-substrate: | 0.991 |
Human Intestinal Absorption (HIA): | 0.77 | 20% Bioavailability (F20%): | 0.99 |
30% Bioavailability (F30%): | 0.986 |
Blood-Brain-Barrier Penetration (BBB): | 0.641 | Plasma Protein Binding (PPB): | 69.58% |
Volume Distribution (VD): | 0.681 | Fu: | 31.74% |
CYP1A2-inhibitor: | 0.001 | CYP1A2-substrate: | 0.993 |
CYP2C19-inhibitor: | 0.021 | CYP2C19-substrate: | 0.464 |
CYP2C9-inhibitor: | 0.018 | CYP2C9-substrate: | 0.014 |
CYP2D6-inhibitor: | 0.002 | CYP2D6-substrate: | 0.074 |
CYP3A4-inhibitor: | 0.875 | CYP3A4-substrate: | 0.556 |
Clearance (CL): | 2.771 | Half-life (T1/2): | 0.174 |
hERG Blockers: | 0.02 | Human Hepatotoxicity (H-HT): | 0.724 |
Drug-inuced Liver Injury (DILI): | 0.564 | AMES Toxicity: | 0.23 |
Rat Oral Acute Toxicity: | 0.948 | Maximum Recommended Daily Dose: | 0.248 |
Skin Sensitization: | 0.035 | Carcinogencity: | 0.966 |
Eye Corrosion: | 0.003 | Eye Irritation: | 0.012 |
Respiratory Toxicity: | 0.981 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC003282 | 0.619 | D0I5DS | 0.248 | ||||
ENC005525 | 0.331 | D0Q4SD | 0.247 | ||||
ENC004027 | 0.323 | D0IL7L | 0.243 | ||||
ENC003376 | 0.295 | D02JNM | 0.242 | ||||
ENC002056 | 0.279 | D0P0HT | 0.241 | ||||
ENC005963 | 0.279 | D04GJN | 0.239 | ||||
ENC003564 | 0.272 | D0IX6I | 0.234 | ||||
ENC005964 | 0.272 | D08PIQ | 0.231 | ||||
ENC003567 | 0.269 | D06IIB | 0.230 | ||||
ENC002033 | 0.269 | D0Y2YP | 0.230 |